hepat
c
viru
hcv
malaria
parasit
plasmodium
use
membran
protein
invad
human
liver
cell
map
host
protein
interact
primari
human
liver
hepatoma
cell
use
highresolut
quantit
proteom
protein
network
identifi
five
protein
hcv
entri
factor
facilit
includ
epiderm
growth
factor
receptor
egfr
notabl
discov
ubiquitin
ligas
casita
blineag
lymphoma
protooncogen
b
cblb
form
complex
support
hcv
entri
cblb
requir
postbind
prerepl
step
hcv
life
cycl
knockout
cblb
reduc
suscept
test
hcv
genotyp
envelop
virus
vesicular
stomat
viru
human
coronaviru
furthermor
plasmodium
sporozoit
reli
distinct
set
interact
partner
liver
cell
entri
find
reveal
comprehens
network
human
liver
cell
show
hcv
plasmodium
highjack
select
interact
includ
cblb
hcv
invad
cell
author
summari
cell
membran
protein
function
entri
factor
hepat
c
viru
hcv
malaria
sporozoit
human
liver
current
remain
enigmat
guid
entri
process
pathogen
whether
function
similar
way
liver
cell
invas
hcv
malaria
parasit
use
high
resolut
quantit
proteom
identifi
associ
host
protein
liver
cell
found
least
protein
form
complex
report
interact
partner
determin
least
five
interactor
plo
pathogen
http
doi
mhhannoverdezibzibhtml
jb
grant
hcv
host
factor
among
ubiquitin
ligas
casita
blineag
lymphoma
protooncogen
b
cblb
test
hcv
genotyp
requir
cblb
full
infect
neither
malaria
parasit
test
envelop
viru
reli
cblb
studi
map
liver
cell
interactom
provid
new
insight
distinct
cell
invas
mechan
hcv
malaria
parasit
liver
site
initi
replic
divers
parenter
transmit
pathogen
hepat
c
viru
hcv
malaria
parasit
plasmodium
enter
liver
sinusoid
infect
hepatocyt
use
two
host
protein
scaveng
receptor
class
b
member
particular
essenti
infect
pathogen
mice
suscept
hcv
express
human
block
human
hepatocyt
impair
p
falciparum
infect
hcv
bind
ectodomain
cointern
clathrinco
vesicl
p
falciparum
murin
parasit
p
yoelii
seem
directli
interact
still
requir
product
uptak
hepatocyt
hcv
entri
tightli
spatiotempor
control
basolater
attach
hcv
subsequ
complex
later
transloc
toward
tight
junction
late
entri
factor
occludin
ocln
resid
cointern
viru
endosom
traffick
step
thought
coordin
epiderm
growth
factor
receptor
egfr
signal
egfr
inde
entri
factor
hcv
acidif
endosom
ph
ultim
lead
fusion
viral
envelop
limit
endosom
membran
deliv
viral
nucleocapsid
cytoplasm
importantli
interact
hcv
induc
conform
chang
surfac
glycoprotein
heterodim
prerequisit
phdepend
fusion
membran
fusion
viral
nucleocapsid
disassembl
releas
viral
genom
cytoplasm
site
viral
genom
translat
replic
uncoat
traffick
thought
requir
serum
respons
factor
bind
protein
recruit
hcv
entri
sum
although
fulfil
multipl
function
hcv
entri
steadyst
interact
partner
requir
hcv
entri
larg
unknown
demand
elucid
employ
combin
quantit
proteomicsrna
interfer
rnai
knockout
strategi
identifi
protein
role
pathogen
liver
cell
entri
previous
identifi
protein
associ
dissoci
hcv
entri
six
role
hcv
infect
ration
viru
induc
interact
potenti
also
preexist
steadi
state
interact
may
play
role
hcv
infect
therefor
determin
high
stringenc
protein
interact
human
hepatoma
cell
primari
human
liver
cell
analysi
differ
coimmunoprecipit
coip
highresolut
quantit
mass
spectrometri
reveal
interact
ten
previous
describ
rnai
knockout
follow
elucid
two
protein
endopeptidas
ubiquitin
ligas
casita
blineag
lymphoma
protooncogen
b
cblb
hcv
host
factor
confirm
role
cblb
hcv
infect
hcv
genotyp
protein
express
intracellularli
seem
affect
postbind
entri
step
hcv
infect
cblb
requir
plasmodium
uptak
final
report
whole
cell
proteom
express
dataset
human
hepatoma
cell
show
strongli
associ
taken
togeth
use
combin
quantit
strategi
map
interact
liver
cell
identifi
cblb
hcv
entri
facilit
pathogen
engag
host
cell
protein
network
gain
access
replic
compet
intracellular
compart
mass
spectrometri
basedproteom
matur
power
technolog
comprehens
analyz
proteinprotein
interact
ppi
cell
cultur
primari
cell
materi
set
appli
labelfre
quantit
lfq
proteom
map
interact
network
hcv
plasmodium
entri
factor
human
liver
cell
fig
therefor
use
human
hepatoma
cell
line
lunet
n
lack
endogen
express
wildtyp
ctermin
hemagglutinin
ha
tag
cell
fig
allow
us
use
antibodi
endogen
tag
epitop
pull
differ
version
bait
confirm
express
respect
protein
immunoblot
immunofluoresc
microscopi
flow
cytometri
wildtyp
hatag
express
cell
surfac
intracellular
compart
compar
endogen
human
hepatoma
cell
fig
lunet
n
cell
lack
detect
express
serv
neg
control
infect
proteom
experi
expectedli
lunet
n
cell
lack
refractori
infect
hcv
lentivirus
pseudotyp
hcv
glycoprotein
reli
hcv
receptor
interact
entri
contrast
express
lunet
n
cell
render
cell
hcv
suscept
fig
next
determin
coip
method
preserv
known
interact
comparison
variou
deterg
reveal
preserv
known
interact
interact
exclud
protein
expect
interact
gapdh
apolipoprotein
fig
fig
moreov
evalu
use
homobifunct
aminereact
cell
membran
imperm
crosslink
bissulfosuccinimidyl
suber
crosslink
allow
pull
control
prey
nonetheless
crosslink
reduc
enrich
one
two
order
magnitud
respect
intens
reduc
captur
may
result
crosslink
larg
protein
aggreg
lost
preclear
lysat
mask
antibodi
epitop
therefor
decid
primarili
analyz
network
lyse
noncrosslink
cell
map
ppi
network
human
hepatoma
cell
perform
total
coip
quadrupl
lunet
cell
lack
express
compar
enrich
data
endogen
bait
hatag
bait
averag
mass
spectrometr
analysi
identifi
protein
fals
discoveri
rate
fdr
peptid
protein
level
tabl
bait
strongli
enrich
order
magnitud
ip
control
ip
fig
expect
posit
neg
control
show
high
low
enrich
respect
among
strongli
enrich
previous
unknown
interactor
identifi
endopeptidas
total
identifi
signific
protein
coimmunoprecipit
express
hepatoma
cell
use
antibodi
target
lel
fig
major
approxim
detect
interact
protein
membran
associ
determin
go
enrich
analysi
fig
interestingli
detect
interactor
fdr
express
cell
use
antibodi
despit
seemingli
similar
subcellular
local
fig
possibl
tag
cytoplasm
tail
weaken
subset
ppi
moreov
observ
even
weaker
protein
enrich
use
antiha
antibodi
indic
pull
e
volcano
plot
visual
twosampl
ttest
compar
lfq
intens
protein
found
lunet
n
lunet
n
protein
ttest
differ
log
versu
control
coip
biolog
replic
plot
p
valu
log
fdr
protein
significantli
enrich
highlight
dark
grey
green
black
white
red
highlight
f
overlap
significantli
enrich
protein
found
lunet
n
lunet
n
see
also
fig
fig
ectodomain
may
preserv
interact
pull
cterminu
express
cell
show
similar
suscept
hcv
express
cell
fig
argu
hcv
infect
relev
interact
preserv
detect
interact
overlap
interactom
fig
tabl
tetraspanin
consist
four
transmembran
domain
one
small
one
larg
extracellular
loop
lel
short
cytosol
domain
lel
bind
directli
glycoprotein
ectodomain
hcv
particl
unclear
domain
mediat
host
ppi
measur
addit
interactom
lunet
cell
presenc
molar
excess
solubl
competit
lel
bind
site
led
strong
reduct
ppi
found
eight
ppi
detect
absenc
lel
label
tabl
fig
underlin
import
function
lel
virion
bind
also
molecular
interact
host
protein
high
confid
potenti
hcv
entri
relev
interact
protein
seven
previous
detect
interactor
name
integrin
g
protein
tetraspanin
postul
papilloma
viru
entri
factor
apolipoprotein
e
apo
moreov
four
protein
report
hcv
entri
facilit
name
epiderm
growth
factor
receptor
egfr
transferrin
receptor
protein
tfrc
ubiquitin
ligas
cbl
label
tabl
taken
togeth
discov
interactor
human
hepatoma
cell
novel
interactor
without
previous
report
function
bind
hcv
cell
invas
see
tabl
full
dataset
unravel
whether
identifi
protein
interact
network
hepatoma
cell
reflect
ppi
primari
human
hepatocyt
develop
second
lfq
affin
enrich
mass
spectrometri
aem
pipelin
fig
due
lack
control
cell
neg
express
perform
isotyp
control
coip
determin
nonspecif
background
bind
protein
ip
resin
fig
analyz
primari
human
hepatocyt
five
donor
sampl
two
donor
pass
qualiti
criteria
name
strong
bait
posit
control
enrich
irrelev
protein
show
similarli
low
abund
specif
control
ip
fig
protein
enrich
control
donor
protein
roughli
annot
membran
associ
fig
tabl
twentythre
interactor
found
primari
human
hepatocyt
overlap
set
hepatoma
cell
interactor
fig
tabl
prey
protein
enrich
limit
coip
hatag
express
cell
perform
second
overlap
analysi
exclus
primari
hepatocyt
hit
enrich
highli
signific
hepatoma
cell
hit
fdr
cell
untag
second
analysi
detect
overlap
protein
includ
ten
novel
protein
fig
found
first
overlap
analysi
fig
note
ten
hit
also
enrich
coip
express
cell
extent
fulfil
stringent
hit
inclus
criteria
roughli
enrich
tabl
novel
hit
togeth
hit
first
overlap
analysi
result
high
confid
interactor
primari
hepatocyt
hepatoma
cell
fig
tabl
fig
summar
protein
abund
bait
protein
interactor
coip
hepatoma
cell
primari
human
hepatocyt
lastli
perform
integr
network
analysi
base
string
david
data
conserv
bind
partner
show
protein
highli
interconnect
previous
report
interact
fig
tabl
network
includ
closest
nine
node
hit
list
follow
result
final
hit
list
protein
ensur
put
network
protein
poorli
amen
ms
identif
still
includ
subsequ
infect
assay
silico
interactor
label
tabl
final
network
molecul
defin
studi
ten
protein
previous
recogn
interactor
includ
integrin
g
protein
apo
prostaglandin
receptor
neg
regul
ptgfrn
six
liver
cell
interactor
found
previous
report
hcv
entri
facilit
describ
label
tabl
addit
lfq
approach
extens
comparison
hepatoma
primari
cell
dataset
elucid
interactor
without
previous
report
role
hcv
entri
bind
summari
defin
stringent
set
interactor
human
liver
cell
fig
tabl
essenti
factor
hcv
plasmodium
sporozoit
entri
liver
cell
mediat
molecular
function
ppi
hypothes
subset
interact
requir
pathogen
product
infect
liver
cell
within
network
protein
inde
found
protein
previous
report
hcv
entri
facilit
integrin
apolipoprotein
egfr
complex
molecul
fig
unravel
yet
unknown
interact
protein
act
pathogen
entri
facilit
investig
human
hepatoma
cell
suscept
hcv
silenc
factor
fig
expectedli
silenc
four
establish
hcv
entri
factor
ocln
reduc
suscept
hcv
mean
zscore
respect
posit
control
fig
silenc
effect
limit
sinc
use
lunet
n
cell
overexpress
five
network
protein
name
ubiquitin
ligas
cblb
cbl
endopeptidas
reduc
suscept
hcv
upon
sirna
silenc
mean
zscore
respect
fig
among
put
hcv
entri
facilit
establish
hcv
entri
factor
entri
facilit
cbl
previous
describ
interactor
moreov
found
two
novel
put
entri
facilit
cblb
discov
interact
partner
hepatoma
cell
primari
human
hepatocyt
fig
includ
cblb
hit
string
network
analysi
fig
silenc
effici
assess
rnai
screen
henc
rule
addit
complex
protein
facilit
hcv
infect
data
underlin
interact
protein
function
hcv
entri
discoveri
cbl
cblb
hcv
host
factor
line
find
show
ubiquitin
show
protein
abund
median
intens
log
hit
bait
indic
coip
sampl
red
blue
color
indic
high
low
intens
differ
respect
see
also
tabl
http
next
set
understand
whether
similar
distinct
set
ppi
necessari
hepatoma
cell
entri
malaria
parasit
plasmodium
yoelii
use
p
yoelii
surrog
system
human
pathogen
p
falciparum
sinc
speci
share
requir
p
yoelii
infect
human
hepatoma
cell
line
p
falciparum
infect
primari
cell
first
evalu
p
yoelii
requir
use
lunet
n
cell
expect
sporozoit
entri
develop
exoerythrocyt
form
eef
strictli
depend
express
fig
contrast
p
berghei
depend
infect
lunet
n
cell
effici
function
block
neutral
antibodi
howev
led
p
berghei
sporozoit
entri
confirm
redund
role
p
berghei
liver
infect
fig
use
p
yoelii
sporozoit
similar
rnai
setup
hcv
fig
identifi
import
host
factor
requir
sporozoit
entri
screen
silenc
pronouncedli
affect
p
yoelii
infect
compar
hcv
infect
suggest
higher
threshold
level
requir
p
yoelii
infect
neither
cblb
knockdown
reduc
plasmodium
sporozoit
entri
significantli
howev
cbl
known
hcv
entri
facilit
reduc
sporozoit
entri
twofold
fig
thu
despit
usag
entri
factor
hcv
plasmodium
sporozoit
distinct
subset
interactor
seem
aid
entri
liver
cell
priorit
cblb
follow
analysi
three
reason
protein
neither
report
interactor
hcv
entri
facilit
previous
moreov
cblb
appear
strongli
associ
complex
total
abund
human
hepatoma
cell
lysat
compar
low
quantifi
intens
base
absolut
quantif
ibaq
lcmsm
analysi
lunet
n
whole
cell
lysat
reveal
moder
express
level
log
ibaq
fig
express
compar
ocln
log
ibaq
lower
log
ibaq
similar
express
pattern
occur
test
human
hepatoma
cell
line
fig
tabl
cblb
includ
silico
predict
network
edg
undetect
lcmsm
howev
could
clearli
show
protein
express
hepatoma
cell
flow
cytometri
immunofluoresc
microscopi
immunoblot
fig
comparison
absolut
abund
enrich
ip
fig
suggest
larg
fraction
associ
human
hepatoma
cell
next
address
subcellular
local
cblb
protein
multipl
cellular
compon
annot
includ
plasma
membran
cytosol
nucleu
human
hepatoma
cell
detect
protein
intracellular
compart
expos
cell
surfac
fig
immunofluoresc
analysi
confirm
express
cytoplasm
nuclear
compart
report
cell
type
fig
cblb
show
weak
coloc
plasma
membran
express
protein
zonula
occluden
pearson
correl
coeffici
respect
fig
verifi
role
cblb
hcv
infect
gener
crispr
knockout
cell
line
lack
cblb
express
fig
control
knockout
cell
line
target
nontarget
singl
guid
rna
sgrna
scrambl
gener
parallel
genom
cblb
knockout
cell
edit
infect
cblb
scrambl
knockout
cell
line
luciferas
report
cell
cultur
viru
hcvcc
genotyp
observ
tenfold
fivefold
reduct
hcv
infect
rate
upon
cblb
knockout
compar
scrambl
control
respect
knockout
almost
complet
abrog
suscept
human
hepatoma
cell
hcv
fig
taken
togeth
find
interact
partner
cblb
hcv
host
depend
factor
find
cblb
form
complex
hcv
receptor
fig
togeth
observ
protein
requir
product
hcv
infect
fig
rais
notion
function
viru
entri
experiment
pinpoint
step
hcv
life
cycl
specif
hcv
entri
protein
affect
assess
hcv
receptor
express
receptor
usag
viru
membran
fusion
uncoat
genom
replic
cblb
knockout
cell
fig
hcv
entri
critic
depend
four
transmembran
protein
olcn
exclud
cblb
serv
entri
factor
chaperon
regul
monitor
surfac
express
level
olcn
cblb
knockout
cell
flow
cytometri
neither
cblb
affect
surfac
express
olcn
human
hepatoma
cell
fig
similarli
egfr
surfac
express
level
remain
unaffect
cblb
knockout
fig
next
analyz
whether
receptor
usag
hcv
impair
cblb
therefor
took
advantag
lentivir
pseudoparticl
display
hcv
surfac
glycoprotein
thu
mimick
receptor
depend
entri
step
neither
cblb
influenc
cell
entri
hcv
glycoprotein
pseudotyp
lentivirus
fig
held
true
test
hcv
genotyp
name
strain
strain
expectedli
cell
lack
express
show
drastic
reduc
hcv
pseudotyp
entri
final
step
hcv
entri
process
phdepend
fusion
viral
envelop
endosom
membran
subsequ
uncoat
viral
nucleocapsid
hcv
membran
fusion
part
mimick
lentivir
pseudotyp
thu
data
suggest
cblb
dispens
entri
step
investig
possibl
role
protein
fusion
uncoat
fuse
hcvcc
particl
plasma
membran
cblb
knockout
cell
low
ph
wash
monitor
infect
rate
assay
entri
natur
rout
prevent
concanamycin
blockag
endosom
acidif
cblb
knockout
cell
display
similar
infect
rate
plasma
membran
bypass
hcv
fusion
inhibitor
flunarizin
reduc
infect
rate
background
level
fig
indic
hcv
membran
fusion
alter
cblb
moreov
hcv
uncoat
unaffect
cblb
address
hcv
postentri
step
ie
genom
translat
replic
entri
independ
assay
transfect
cell
hcv
subgenom
rna
fig
transfect
effici
compar
test
cell
line
fig
replic
rate
significantli
affect
cblb
knockout
fig
observ
slightli
reduc
replic
h
post
transfect
cblb
knockout
cell
replic
defici
subgenom
hcv
delta
gdd
fail
replic
cell
line
expect
subgenom
genotyp
full
length
genotyp
replicon
show
compar
result
genotyp
subgenom
fig
lastli
test
whether
cblb
affect
assembl
releas
new
virion
cell
infect
supernat
full
length
rna
genom
transfect
cell
larg
independ
presenc
cblb
fig
slight
reduct
infecti
titer
observ
knockout
cell
togeth
data
suggest
cblb
affect
primarili
postbind
prefus
life
cycl
step
mimick
lentivir
pseudoparticl
assess
whether
cblb
support
viru
life
cycl
step
share
rna
virus
replic
cytoplasm
compart
infect
knockout
cell
human
coronaviru
hcov
strain
vesicular
stomat
viru
vsv
strain
indiana
fig
cblb
dispens
cov
vsv
infect
human
hepatoma
cell
fig
similarli
p
yoelii
p
berghei
sporozoit
enter
cblb
knockout
cell
least
effici
control
cell
fig
contrast
cblb
necessari
full
infect
test
hcv
genotyp
fig
reveal
pangenotyp
requir
cblb
complement
cblb
knockout
cell
either
enzymat
activ
dead
variant
protein
led
twofold
increas
hcv
suscept
fig
confirm
find
use
nonreport
genotyp
hcv
strain
cblb
knockout
cell
show
drop
titer
releas
hcv
rescu
either
wildtyp
activ
site
mutant
cblb
fig
shed
light
cblb
domain
requir
hcv
infect
overexpress
full
length
truncat
domain
mutant
cblb
lunet
n
cell
fig
overexpress
full
length
ntermin
proteas
core
domain
two
ctermin
domain
increas
basal
hcv
infect
threefold
overexpress
cblb
full
length
ntermin
tyrosin
kinas
bind
tkb
ring
finger
domain
ring
finger
domain
togeth
ctermin
prolinerich
ubiquitin
associ
domain
uba
led
maximum
increas
hcv
infect
fig
suggest
cblb
function
hcv
entri
independ
enzymat
signal
function
ie
protein
scaffold
function
taken
togeth
studi
reveal
role
ppi
product
hcv
entri
specif
unravel
cblb
host
entri
facilit
guid
product
uptak
hcv
lipoviroparticl
replic
compet
intracellular
site
studi
identifi
cblb
compon
receptor
complex
hcv
entri
facilit
demonstr
hcv
bind
liver
cell
surfac
interactor
hcv
entri
factor
isol
event
steadi
state
protein
interact
requir
virion
uptak
specif
map
protein
interact
rest
human
hepatocyt
demonstr
subset
preexist
interact
necessari
hcv
infect
tetraspanin
organ
membran
microdomain
signal
platform
cell
type
specif
manner
b
lymphocyt
serv
clamp
b
cell
receptor
complex
liver
cell
littl
inform
guid
membran
protein
complex
avail
reflect
limit
knowledg
endogen
function
liver
identifi
associ
protein
rel
strength
interact
determin
abund
coip
depict
center
network
fig
plu
nine
closest
neighbor
network
protein
use
string
network
ingenu
pathway
david
go
enrich
analysi
network
protein
liver
cell
found
ephrin
receptor
signal
ephrin
b
signal
thrombin
signal
tec
kinas
signal
top
four
biolog
pathway
log
p
fig
notabl
ephrin
receptor
serv
entri
facilit
hcv
virus
nipah
viru
kaposi
sarcoma
herpesviru
top
four
associ
diseas
disord
reflect
report
role
cell
migrat
includ
organism
injuri
molecul
cancer
molecul
inflammatori
respons
molecul
infecti
diseas
molecul
fig
notion
involv
receptor
complex
cell
migrat
strengthen
associ
interactom
follow
molecular
cellular
function
celltocel
signal
molecul
cell
movement
molecul
cell
morpholog
molecul
fig
two
top
rank
cellular
network
associ
interactom
liver
cell
celltocel
signal
movement
score
focu
molecul
infecti
diseas
score
focu
molecul
fig
analysi
suggest
role
integrin
g
protein
coordin
well
tfrc
egfr
signal
latter
two
receptor
hcv
entri
facilit
highlight
heredefin
interactom
inde
reveal
host
factor
role
pathogen
invas
liver
report
hcv
host
factor
cblb
ligas
function
togeth
cbl
cblb
cbl
regul
egfr
endocytosi
ubiquitin
cytosol
receptor
domain
notabl
egfr
cbl
known
hcv
entri
facilit
analysi
suggest
egfr
cbl
cblb
form
complex
liver
cell
cbl
cblb
necessari
full
hcv
suscept
found
ligas
activ
cblb
dispens
promot
hcv
uptak
line
ligas
activ
independ
role
cblb
b
cell
receptor
intern
cblb
known
coordin
egfr
intern
togeth
cbl
other
describ
hcv
entri
facilit
togeth
find
suggest
cblb
scaffold
function
egfr
driven
endocytosi
platform
futur
studi
possibl
use
recent
develop
organoid
model
singl
particl
track
hcv
may
shed
light
spatiotempor
role
cblb
hcv
entri
studi
certain
previous
known
hcv
entri
facilit
egfr
trfc
influenc
hcv
suscept
upon
knockdown
given
assay
condit
howev
control
silenc
effici
use
serum
contain
condit
therefor
especi
growth
factor
transferrin
depend
entri
facilit
presum
escap
detect
thu
import
note
rnai
screen
may
miss
interact
protein
role
hcv
p
yoelii
infect
cblb
cbl
identifi
interact
partner
given
experiment
condit
presum
transient
bind
ligas
subsequ
target
protein
complex
proteasom
degrad
hamper
detect
ubiquitin
ligas
substrat
trap
method
may
overcom
experiment
limit
studi
could
overcom
caveat
silico
network
analysi
inclus
closest
network
node
function
valid
model
link
signal
platform
serv
entri
microdomain
line
recent
report
influenza
viru
entri
influenza
viru
interact
sialyl
molecul
cell
surfac
caus
cluster
lipid
raft
activ
raftassoci
signal
molecul
includ
egfr
latter
activ
endocytosi
togeth
influenza
viru
interest
investig
whether
cbl
cblb
affect
influenza
viru
entri
similar
manner
hcv
entri
tetraspanin
moreov
play
role
entri
spread
human
papillomavirus
human
cytomegaloviru
thu
studi
provid
import
dataset
ppi
implic
beyond
hcv
infect
fact
think
unbias
interact
proteom
provid
differ
perspect
viru
entri
function
knockout
screen
open
avenu
divers
function
follow
studi
hypothesi
gener
absenc
infect
thought
regul
migrat
liver
cell
confirm
notion
silico
analysi
map
identifi
network
protein
cellular
movement
pathway
notabl
express
interactor
hcv
entri
facilit
cblb
alter
gastric
breast
tumor
tissu
cblb
regul
cell
migrat
epiderm
mesenchym
transit
emt
egfr
degrad
line
recent
report
hcv
entri
facilit
like
e
cadherin
contribut
emt
progress
hcv
infect
tissu
liver
cancer
slow
indirect
multifactori
process
network
analysi
suggest
cellular
ppi
engag
viru
entri
might
link
tumor
develop
specif
hcv
entri
process
occur
infect
liver
may
contribut
emt
long
run
tip
balanc
toward
tumor
format
calcium
depend
endopeptidas
predict
regul
protein
function
limit
proteolysi
express
lung
kidney
brain
previous
report
demonstr
express
primari
hepatocyt
hepatoma
cell
moreov
show
associ
protein
complex
requir
hcv
entri
data
suggest
put
endopeptidas
function
dispens
hcv
infect
scaffold
function
note
poorli
character
cellular
function
well
substrat
remain
enigmat
work
show
function
hcv
entri
independ
predict
catalyt
triad
whether
endogen
function
mediat
predict
endopeptidas
function
remain
investig
find
cblb
necessari
hcv
infect
hcv
translat
replic
assembl
releas
virion
strongli
indic
role
viru
entri
specif
cblb
regul
entri
step
mimick
lentivir
pseudoparticl
two
major
differ
lentivir
pseudoparticl
authent
hcv
particl
exist
firstli
hcv
contrast
lentivir
pseudoparticl
tightli
associ
serum
lipoprotein
form
lipoviroparticl
secondli
hcv
replic
special
cytoplasmat
compart
lentivirus
replic
nucleu
data
point
toward
role
cblb
guid
endosom
uptak
traffick
hcv
replic
compet
cytoplasm
compart
model
support
notion
endosom
sort
depend
membran
proteinlipid
complex
correct
endosom
rout
critic
product
viru
infect
thu
propos
model
cblb
regul
endosom
uptak
hcvreceptor
complex
subsequ
rout
toward
replic
compet
subcellular
compart
fig
data
confirm
hcv
malaria
parasit
plasmodium
use
distinct
entri
pathway
liver
cell
invas
line
fact
hcv
critic
reli
host
cell
endocyt
machineri
plasmodium
motil
organ
enter
cell
activ
use
motor
machineri
moreov
differ
region
ectodomain
requir
hcv
plasmodium
entri
respect
line
demonstr
cblb
promot
hcv
entri
plasmodium
entri
human
hepatoma
cell
interestingli
growth
factor
receptor
implic
entri
process
hcv
plasmodium
suggest
interact
partner
may
hijack
pathogen
studi
identifi
cbl
common
entri
facilit
fact
activ
growth
factor
receptor
like
differ
pathogen
plasmodium
thrombosponinrel
anonym
protein
trap
directli
activ
host
kinas
hcv
probabl
induc
kinas
receptor
cluster
mechanist
detail
howev
remain
elucid
interestingli
egfr
associ
molecul
score
posit
hcv
plasmodium
rna
interfer
screen
hcv
reli
cbl
cblb
plasmodium
reli
cbl
egfr
adaptor
protein
also
report
hcv
entri
facilit
show
cblb
knockdown
knockout
cell
fulli
function
plasmodium
uptak
highlight
versatil
follow
receptor
interact
proteom
demonstr
similar
differ
usag
hcv
plasmodium
virus
contribut
estim
adapt
chang
human
proteom
suggest
protect
protein
network
evolv
fend
viru
attack
cell
rnai
data
suggest
steadi
state
interact
hcv
receptor
liver
cell
nonprotect
studi
concentr
interact
occur
suscept
primari
liver
cell
hepatoma
cell
latter
adapt
support
full
hcv
life
cycl
notabl
found
signific
number
primari
hepatocyt
specif
interact
follow
function
studi
conceiv
interact
protect
togeth
stronger
innat
immun
respons
primari
hepatocyt
compar
highli
hcvadapt
hepatoma
cell
line
could
explain
low
suscept
primari
cell
hcv
infect
patient
slow
diseas
progress
limit
viral
spread
liver
symptom
occur
year
post
contract
reflect
phenotyp
futur
work
clarifi
exist
protect
protein
network
primari
hepatocyt
clearli
interact
network
nonsuscept
cell
like
b
cell
markedli
differ
describ
liver
cell
network
confirm
notion
interactor
like
contribut
narrow
tissu
tropism
hcv
system
biolog
approach
prove
increasingli
valuabl
understand
virus
caus
diseas
proteom
method
contrast
genom
transcriptom
method
past
decad
reach
resolut
throughput
necessari
systemat
analysi
host
pathogen
interact
overal
proteom
profil
infect
cell
importantli
protein
interact
profil
combin
comput
biolog
iter
process
ultim
map
near
complet
cellular
network
futur
may
abl
predict
silico
perturb
network
pathogen
influenc
cellular
function
current
studi
describ
isol
network
plasma
membran
protein
tetraspanin
function
cell
motil
confirm
found
integrin
small
g
protein
gtpase
growth
factor
receptor
involv
cell
migrat
network
molecul
current
knowledg
hcv
use
two
molecul
egfr
cell
entri
plasmodium
presum
none
molecul
involv
cell
migrat
thu
design
antimicrobi
drug
minim
side
effect
endogen
function
may
possibl
importantli
pathogen
may
use
protein
domain
function
requir
endogen
role
protein
indic
function
activ
site
mutant
cblb
hcv
entri
may
thu
feasibl
specif
target
protein
function
use
pathogen
therebi
exclud
minim
side
effect
furthermor
system
virolog
approach
use
primari
cell
materi
numer
donor
hold
promis
elucid
individu
differ
protein
express
network
therebi
spur
person
medicin
conclus
studi
impact
understand
hcv
entri
pathogenesi
also
set
stage
elucid
hcv
driven
carcinogenesi
entri
malaria
parasit
liver
lunet
n
cell
subclon
use
studi
design
lunet
n
describ
detail
lunet
n
deriv
cell
line
cultur
dulbecco
modifi
eagl
medium
invitrogen
supplement
fc
fc
gold
paa
coelb
germani
mm
lglutamin
invitrogen
mm
nonessenti
amino
acid
invitrogen
uml
penicillin
invitrogen
streptomycin
invitrogen
lunet
n
lunet
n
fluc
cultur
presenc
blasticidin
invivogen
primari
human
hepatocyt
isol
liver
specimen
plate
collagenco
dish
cellswel
describ
antibodi
clone
sigma
abcam
cblb
invitrogen
clone
sant
cruz
clone
db
pharmigen
r
egfr
clone
merck
gapdh
sigma
ha
clone
covanc
clone
kindli
provid
charl
rice
ocln
clone
invitrogen
scarbi
novu
clone
bd
bioscienc
use
immunoblot
flow
cytometri
immunofluoresc
stain
horseradish
peroxidas
hrp
coupl
antimous
antirabbit
antibodi
sigma
jackson
lab
inc
respect
alexa
secondari
antibodi
lifetechnolog
alexa
secondari
antibodi
invitrogen
apcor
fitcconjug
secondari
antibodi
ebiosci
immunoprecipit
use
antibodi
clone
santa
cruz
ha
clone
covanc
mous
igg
clone
bd
pharmigen
western
blot
analysi
equival
volum
cell
lysat
ip
flowthrough
ip
eluat
boil
min
sd
sampl
buffer
nonreduc
condit
resolv
sdspage
transfer
pvdf
membran
electroblot
membran
probe
primari
antibodi
secondari
hrp
conjug
antibodi
h
room
temperatur
analyz
use
chemiluminesc
inta
system
flow
cytometri
cell
trypsin
quench
surfac
stain
primari
antibodi
pb
contain
fc
min
ice
brief
wash
secondari
secondari
antibodi
ad
min
ice
cell
wash
three
time
analyz
facsaccuri
bd
bioscienc
data
analysi
perform
use
flowjo
immunofluoresc
analysi
cell
plate
polylysin
coat
cover
slip
fix
paraformaldehyd
min
three
pb
wash
cell
permeabil
min
anticblb
antibodi
peradsorb
night
cblb
knockout
cell
respect
scrambl
knockout
cell
incub
preadsorb
antibodi
follow
stain
h
rt
secondari
alexafluorophor
conjug
antibodi
dapi
counterstain
cell
mount
glass
slide
prolong
gold
antifad
mountant
molecular
probe
analyz
confoc
microscopi
use
invers
confoc
laserscan
microscop
olympu
fluoview
use
magnif
len
three
channel
blue
green
red
read
sequenti
acquisit
mode
averag
frame
pictur
kalman
n
data
analysi
perform
use
fluoview
olympu
imag
j
intens
correl
analysi
perform
use
imag
j
coloc
analysi
plugin
pearson
coloc
coeffici
calcul
least
six
individu
frame
knockout
cell
gener
describ
main
text
tabl
list
sgrna
use
target
indic
gene
scrambl
nontarget
sgrna
use
control
control
disrupt
target
gene
sgrna
bind
region
amplifi
sequenc
use
primer
list
tabl
singl
guid
rna
sgrna
sequenc
select
use
chopchop
clone
plenti
crispr
ccdb
describ
lentivir
vsvg
pseudotyp
particl
gener
use
standard
procedur
cell
hepatoma
target
cell
transduc
lentivirus
h
hpt
cell
select
sgrna
express
puromycin
select
surviv
cell
character
flow
cytometr
antibodi
stain
batch
knockout
popul
valid
immunoblot
sequenc
edit
genom
dna
region
complement
knockout
cell
sgrnaresist
cblbconstruct
gener
end
cblb
amplifi
mlui
spei
bind
site
ad
use
follow
primer
pair
gcgtgccaccatgttctcg
aaaactagtctatagatttagac
cblb
sgrna
bind
site
resist
gener
use
cblb
sgrnaresist
construct
use
gener
activ
site
mutant
follow
primer
use
introduc
mutat
three
activ
site
tgcccacctgg
cc
gcctgcgcgccccctggggcg
cblb
follow
primer
use
introduc
activ
site
mutat
construct
amino
acid
well
cblb
construct
cblb
amino
acid
design
contain
tandem
hemagglutinin
ha
tag
cterminu
via
gli
sergli
linker
order
gblock
gene
fragment
idt
usa
dna
fragment
clone
pwpiblr
vector
use
gibson
assembl
accord
manufactur
instruct
new
england
biolab
ipswich
usa
hcv
full
length
intergenotyp
chimera
subgenom
rna
vitro
transcrib
use
transfect
cell
previous
describ
analyz
replic
independ
entri
cell
transfect
subgenom
replicon
lyse
h
post
transfect
luciferas
activ
measur
infect
full
length
hcv
stock
gener
describ
use
infect
cell
h
follow
luciferas
measur
cell
lysat
infect
perform
moi
quantifi
harvest
cell
cultur
supernat
h
post
infect
subsequ
titrat
cell
limit
dilut
immunohistochemistri
readout
h
post
infect
recombin
vsv
express
gfp
kindli
provid
gert
zimmer
cell
infect
vsvgfp
h
follow
quantif
gfp
signal
via
flow
cytometri
use
accuri
bd
human
coronaviru
express
renilla
reniformi
luciferas
kindli
provid
volker
thiel
use
infect
cell
h
follow
luciferas
measur
cell
lysat
lentivir
pseudoparticl
encod
firefli
luciferas
gener
describ
subsequ
target
cell
transduc
pseudoparticl
h
cell
lyse
luciferas
signal
quantifi
lentivir
pseudoparticl
encod
sgrna
code
sequenc
cblb
carri
vsv
glycoprotein
gener
use
protocol
subsequ
target
cell
transduc
pseudoparticl
cell
cultur
analysi
analyz
fusion
hcv
particl
plasma
membran
perform
fusion
assay
describ
brief
cell
seed
cellswel
polyllysin
coat
well
plate
cell
pretreat
h
nm
concanamycin
inhibit
acidif
endosom
subsequ
produc
describ
allow
bind
h
presenc
concanamycin
viru
remov
cell
shift
h
presenc
concanamycin
induc
prime
glycoprotein
bound
viru
afterward
fusion
trigger
min
wash
ph
citric
buffer
ph
citric
buffer
use
control
cell
incub
anoth
h
medium
contain
concanamycin
medium
replac
luciferas
activ
measur
hpi
control
fusion
inhibitor
flunarizin
ad
addit
concanamycin
solubl
form
fuse
glutathionestransferas
gst
produc
describ
short
escherichia
coli
rosetta
gami
transfect
plasmid
encod
fusion
protein
grown
od
follow
induct
protein
express
addit
mm
iptg
sigma
aldrich
h
subsequ
bacteria
pellet
lyse
freez
liquid
n
sonic
gstfusion
protein
recov
affin
chromatographi
use
glutathion
agaros
sigma
overnight
next
day
agaros
wash
three
time
pb
gstfusion
protein
elut
three
step
mm
lglutathion
sigma
dialyz
pb
overnight
concentr
elut
protein
determin
bradford
assay
onestep
immunoprecipit
membran
protein
perform
use
aminolink
plu
protein
ag
resin
pierc
coval
bound
clone
santa
cruz
clone
covanc
igg
isotyp
control
clone
bd
pharmigen
antibodi
associ
protein
elut
resin
use
glycin
buffer
ph
precipit
ethanol
sodium
acet
ph
glycogen
describ
elsewher
experi
conduct
four
biolog
replic
four
independ
hepatoma
cell
passag
primari
human
hepatocyt
coip
perform
singl
experi
seven
independ
donor
effici
bait
enrich
determin
hepatoma
cell
ip
sampl
ip
two
primari
cell
donor
immunoblot
hepatoma
cell
ip
eluat
ip
primari
cell
five
independ
donor
use
liquid
chromatographi
tandem
mass
spectrometri
lcmsm
analysi
hepatoma
cell
pellet
lyse
sd
mm
hepe
ph
mm
dtt
cell
heat
min
sonic
min
level
bioruptor
diagenod
protein
precipit
aceton
overnight
resuspend
next
day
urea
mm
hepe
ph
proteolyt
digest
carri
describ
sampl
subject
lcmsm
analysi
protein
sampl
reduc
alkyl
trypsin
previous
describ
tryptic
peptid
separ
easynlc
hplc
system
coupl
onlin
orbitrap
mass
spectromet
q
exact
hf
thermo
fisher
scientif
via
nanoelectrospray
sourc
singl
run
experi
data
acquir
use
xcalibur
softwar
thermo
scientif
ms
raw
file
analyz
use
maxquant
algorithm
human
uniprot
fasta
databas
common
contamin
databas
entri
andromeda
search
engin
fals
discoveri
rate
fdr
peptid
protein
level
inclus
criteria
set
least
one
uniqu
razor
peptid
minimum
length
amino
acid
per
protein
group
maxlfq
algorithm
use
protein
quantif
statist
analysi
proteom
data
conduct
use
nonparametr
two
sampl
test
correct
multipl
hypothesi
test
perseu
protein
significantli
enrich
coip
hepatoma
cell
fdr
minim
log
fold
chang
primari
hepatocyt
intens
differ
consid
analysi
interact
partner
fulfil
criterion
function
follow
bind
protein
addit
includ
nine
closest
node
string
network
analysi
base
experiment
data
databas
search
confid
protein
result
bind
partner
test
role
hcv
infect
hierarch
cluster
integr
network
analysi
includ
go
annot
describ
previous
center
network
hit
visual
use
cytoscap
version
median
intens
differ
measur
interact
strength
protein
interact
public
submit
imex
http
wwwimexconsortiumorg
consortium
intact
assign
identifi
lunet
n
cell
stabli
express
firefli
luciferas
lunet
n
fluc
transfect
pool
three
sirna
target
select
interact
partner
ambion
silenc
select
infect
renilla
luciferas
report
viru
detail
screen
conduct
nine
time
cell
three
independ
passag
normal
statist
analysi
perform
set
target
includ
posit
control
r
use
bioconductor
packag
rnaither
briefli
normal
plate
effect
done
subtract
plate
mean
divid
plate
standard
deviat
gfpexpress
p
yoelii
p
berghei
collect
salivari
gland
infect
anophel
stephensi
mosquito
lunet
n
lunet
n
cell
x
cellswel
plate
well
plate
hour
prior
infect
coincub
hour
sporozoit
x
well
wash
remov
extracellular
parasit
cultur
hour
infect
cultur
analyz
fluoresc
microscopi
fixat
pfa
stain
antibodi
specif
parasitophor
membran
marker
nuclear
stain
hoechst
experi
perform
least
three
biolog
replic
three
technic
replic
per
experi
unless
otherwis
state
result
present
mean
plu
standard
deviat
sd
three
biolog
replic
unless
otherwis
indic
tissu
cultur
infecti
dose
calcul
base
kaerber
spearman
statist
signific
determin
oneway
analysi
varianc
anova
follow
dunnett
multipl
comparison
test
unpair
test
graphpad
prism
graphpad
softwar
inc
san
diego
p
valu
less
consid
statist
signific
ethic
commiss
hannov
medic
school
approv
studi
primari
hepatocyt
vote
patient
adult
gave
written
inform
consent
studi
perform
complianc
ethic
standard
laid
declar
helsinki
tabl
lfq
dataset
coip
lunet
n
cell
protein
abund
human
hepatoma
cell
coip
list
detect
protein
intens
differ
control
coip
experiment
condit
pleas
refer
excel
file
xlsx
tabl
lfq
statist
coip
lunet
n
cell
welch
test
differ
p
valu
signific
copurifi
protein
human
hepatoma
cell
tab
fdr
tab
fdr
pleas
refer
excel
file
xlsx
